Celularity Inc. - Class A Common Stock (CELU)
2.0999
-0.0401 (-1.87%)
NASDAQ · Last Trade: Jul 17th, 10:30 AM EDT
Via Benzinga · July 16, 2025
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · July 16, 2025
Via Benzinga · July 16, 2025
Via Benzinga · July 16, 2025
Via Benzinga · July 15, 2025
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via Chartmill · July 15, 2025
Celularity Inc. (NASDAQ: CELU) saw an 8.04% rise in stock value during pre-market hours on Tuesday due to a regulatory change.
Via Benzinga · July 15, 2025

Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.
Via Chartmill · March 5, 2025

Via Benzinga · November 7, 2024

Via Benzinga · March 13, 2024

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Via Benzinga · February 26, 2024

Via Benzinga · February 23, 2024

Via Benzinga · February 9, 2024

Via Benzinga · February 2, 2024

Via Benzinga · February 2, 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 250 points on Thursday. The Dow traded up 0.66% to 38,403.91 while the NASDAQ rose 1.01% to 15,316.80. The S&P 500 also rose, gaining, 0.87% to 4,887.70.
Via Benzinga · February 1, 2024

Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results.
Via Benzinga · February 1, 2024

Via Benzinga · February 1, 2024

U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.5% on Thursday. The Dow traded up 0.23% to 38,238.99 while the NASDAQ rose 0.54% to 15,245.46. The S&P 500 also rose, gaining, 0.48% to 4,868.71.
Via Benzinga · February 1, 2024

Via Benzinga · January 30, 2024

Via Benzinga · January 24, 2024

Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announced an agreement to divest ophthalmology franchise to Sandoz in $170 million upfront all cash deal.
Via Benzinga · January 22, 2024

Via Benzinga · January 22, 2024

Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the consensus of $1.532 billion. Adjusted EPS of 25 cents topped the street view of 23 cents.
Via Benzinga · January 18, 2024